These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31999665)

  • 1. Drugs for psoriatic arthritis.
    Med Lett Drugs Ther; 2019 Dec; 61(1588):203-210. PubMed ID: 31999665
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2018 Jul; 60(1552):123-128. PubMed ID: 30044766
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2021 Nov; 63(1637):177-184. PubMed ID: 35085210
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for psoriasis.
    Med Lett Drugs Ther; 2019 Jun; 61(1574):89-96. PubMed ID: 31381544
    [No Abstract]   [Full Text] [Related]  

  • 5. Expanded table: some drugs for psoriasis.
    Med Lett Drugs Ther; 2019 Jun; 61(1574):e96-e103. PubMed ID: 31381545
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanded Table: Some biologic drugs and JAK inhibitors for rheumatoid arthritis.
    Med Lett Drugs Ther; 2021 Nov; 63(1637):e187-e189. PubMed ID: 35085212
    [No Abstract]   [Full Text] [Related]  

  • 7. Tildrakizumab (Ilumya) - another IL-23 antagonist for psoriasis.
    Med Lett Drugs Ther; 2019 Jan; 60(1563):4-6. PubMed ID: 30681661
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2018 Jul; 60(1550):107-114. PubMed ID: 30036352
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for plaque psoriasis.
    Med Lett Drugs Ther; 2024 Sep; 66(1712):153-160. PubMed ID: 39302348
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison table: Some drugs for plaque psoriasis.
    Med Lett Drugs Ther; 2024 Sep; 66(1712):e160-e166. PubMed ID: 39302349
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.
    Kerschbaumer A; Smolen JS; Dougados M; de Wit M; Primdahl J; McInnes I; van der Heijde D; Baraliakos X; Falzon L; Gossec L
    Ann Rheum Dis; 2020 Jun; 79(6):778-786. PubMed ID: 32381564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison table: some drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2018 Jul; 60(1550):e117-e122. PubMed ID: 30036356
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
    Gan EY; Chong WS; Tey HL
    BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New targets in psoriatic arthritis.
    Braun J
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii30-ii37. PubMed ID: 27856658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis.
    Lu C; Wallace BI; Waljee AK; Fu W; Zhang Q; Liu Y
    Semin Arthritis Rheum; 2019 Dec; 49(3):381-388. PubMed ID: 31272807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis.
    Ungprasert P; Thongprayoon C; Davis JM
    Semin Arthritis Rheum; 2016 Feb; 45(4):428-38. PubMed ID: 26610638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis.
    Ash Z; Gaujoux-Viala C; Gossec L; Hensor EM; FitzGerald O; Winthrop K; van der Heijde D; Emery P; Smolen JS; Marzo-Ortega H
    Ann Rheum Dis; 2012 Mar; 71(3):319-26. PubMed ID: 21803753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded table: Some drugs for inflammatory bowel disease.
    Med Lett Drugs Ther; 2023 Jul; 65(1680):e115-e119. PubMed ID: 37418332
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug safety evaluation of apremilast for treating psoriatic arthritis.
    Busa S; Kavanaugh A
    Expert Opin Drug Saf; 2015 Jun; 14(6):979-85. PubMed ID: 25827658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risankizumab (Skyrizi) for psoriasis.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):81-83. PubMed ID: 31170118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.